首页> 外文期刊>Science >Transferrin receptor 1 is a reticulocyte-specific receptor for Plasmodium vivax
【24h】

Transferrin receptor 1 is a reticulocyte-specific receptor for Plasmodium vivax

机译:转铁蛋白受体1是间质疟原虫的网状细胞特异性受体

获取原文
获取原文并翻译 | 示例
       

摘要

Plasmodium vivax shows a strict host tropism for reticulocytes. We identified transferrin receptor 1 (TfR1) as the receptor for P. vivax reticulocyte-binding protein 2b (PvRBP2b). We determined the structure of the N-terminal domain of PvRBP2b involved in red blood cell binding, elucidating the molecular basis for TfR1 recognition. We validated TfR1 as the biological target of PvRBP2b engagement by means of TfR1 expression knockdown analysis. TfR1 mutant cells deficient in PvRBP2b binding were refractory to invasion of P. vivax but not to invasion of P. falciparum. Using Brazilian and Thai clinical isolates, we show that PvRBP2b monoclonal antibodies that inhibit reticulocyte binding also block P. vivax entry into reticulocytes. These data show that TfR1-PvRBP2b invasion pathway is critical for the recognition of reticulocytes during P. vivax invasion.
机译:间质疟原虫对网状细胞显示出严格的宿主向性。我们确定转铁蛋白受体1(TfR1)为间日疟原虫网状细胞结合蛋白2b(PvRBP2b)的受体。我们确定了参与红细胞结合的PvRBP2b N末端结构域的结构,阐明了TfR1识别的分子基础。我们通过TfR1表达敲低分析验证了TfR1是PvRBP2b参与的生物学目标。缺乏PvRBP2b结合的TfR1突变细胞难于间日疟原虫的入侵,但对恶性疟原虫的入侵不是难治的。使用巴西和泰国临床分离株,我们显示抑制网织红细胞结合的PvRBP2b单克隆抗体也阻断间日疟原虫进入网织红细胞。这些数据表明,TfR1-PvRBP2b入侵途径对于间日疟原虫入侵期间网织细胞的识别至关重要。

著录项

  • 来源
    《Science》 |2018年第6371期|48-55|共8页
  • 作者单位

    Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia;

    Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA;

    Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia;

    Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia;

    Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, Singapore 117597, Singapore;

    Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia;

    Ulm Univ, Inst Pharmacol Nat Prod & Clin Pharmacol, Ulm, Germany;

    Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia;

    Cambridge Inst Med Res, Cambridge CB2 OXY, England;

    Wellcome Trust Sanger Inst, Cambridge, England;

    Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA;

    La Trobe Univ, La Trobe Inst Mol Sci, Melbourne, Vic 3086, Australia;

    Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia;

    Cambridge Inst Med Res, Cambridge CB2 OXY, England;

    Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia;

    Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia;

    Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA;

    Mahidol Univ, Shoklo Malaria Res Unit, Mahidol Oxford Trop Med Res Unit, Fac Trop Med, Mae Sot, Thailand;

    Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Sao Paulo, Brazil;

    Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Sao Paulo, Brazil;

    Univ Otago, Dept Microbiol & Immunol, Dunedin 9054, New Zealand;

    ASTAR, Singapore Immunol Network, Singapore 138648, Singapore;

    Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA;

    Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 02:51:02

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号